STAB - Statera BioPharma Inc
Previous close
0.0006
0 0%
Share volume: 5,122
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
Summary score
25%
Profitability
25%
Dept financing
18%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2017 - 31-Dec-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
421.45%
Return on assets
-23.37%
Return on sales
-938.13%
Return on invested capital
-20.28%
Total debt ratio
159%
Debt ratio change over timeo
0.87%
Current Ratio
8.45%
Quick Ratio
8.45%
Cash Position Ratio
8.13%
Short-term ratios 31-Dec-2020 - 31-Dec-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
1394.29%
Return on assets
-28.08%
Return on sales
-2833.54%
Return on invested capital
-302.76%
Total debt ratio
51.78%
Debt ratio change over timeo
-1.45%
Current Ratio
19%
Quick Ratio
19%
Cash Position Ratio
18.79%
Last quarter ratios 31-Dec-2021
The data are presented for the financials results of the last quarter.
Return on equity
5607.86%
Return on assets
-93.9%
Return on sales
-1589.62%
Return on invested capital
-1522.1%
Total debt ratio
107.41%
Debt ratio change over time
-1.07%
Current Ratio
0.37%
Quick Ratio
0.37%
Cash Position Ratio
0.18%
Performance ratios (change over 4 years) 31-Dec-2017 - 31-Dec-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-91.95%
Return on assets
-118.56%
Return on sales
-1011.43%
Return on invested capital
-106.42%
Total debt ratio
87.46%
Debt ratio change over time
0.87%
Current Ratio
-15.81%
Quick Ratio
-15.81%
Cash Position Ratio
-16.12%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | STAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 421.45% | -6.12% | 17.44% | 8.57% |
| Return on assets | -23.37% | 3.34% | 3.74% | 6.3% |
| Return on sales | -938.13% | 30.6% | 38.94% | 39.41% |
| Return on invested capital | -20.28% | 4.73% | 8.37% | 21.65% |
| Profitability | 25% | 38% | 50% | 76% |
| Total debt ratio | 159% | 100.81% | 83.14% | 28.81% |
| Debt ratio change over time | 0.87% | 265.19% | 10.81% | 1.15% |
| Dept financing | 25% | 41% | 14% | 5% |
| Current Ratio | 19% | 0.89% | 1.55% | 3.49% |
| Quick Ratio | 19% | 0.78% | 1.25% | 2.93% |
| Cash Position Ratio | 18.79% | 0.33% | 0.73% | 1.29% |
| Liquididy | 75% | 9% | 15% | 25% |
| Short-term ratios | STAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1394.29% | 20.29% | 18.63% | 12.78% |
| Return on assets | -28.08% | 3.26% | 3.68% | 9.96% |
| Return on sales | -2833.54% | 34.28% | 35.24% | 53.66% |
| Return on invested capital | -302.76% | 3.23% | 5.33% | 37.78% |
| Profitability | 25% | 27% | 30% | 75% |
| Total debt ratio | 51.78% | 90.69% | 86.92% | 28.88% |
| Debt ratio change over time | -1.45% | 44.47% | 21.24% | -0.09% |
| Dept financing | 14% | 50% | 36% | 8% |
| Current Ratio | 19% | 0.89% | 1.55% | 3.49% |
| Quick Ratio | 19% | 0.78% | 1.25% | 2.93% |
| Cash Position Ratio | 18.79% | 0.33% | 0.73% | 1.29% |
| Liquididy | 75% | 3% | 5% | 10% |